Able 0 4 0 4 O
to 5 7 5 7 O
take 8 12 8 12 O
aspirin 13 20 13 20 B-treatment
( 21 22 21 22 O
81 22 24 22 24 B-lower_bound
or 25 27 25 27 O
325 28 31 28 31 B-upper_bound
mg 32 34 32 34 I-upper_bound
) 34 35 34 35 O
daily 36 41 36 41 O
as 42 44 42 44 O
prophylactic 45 57 45 57 B-treatment
anticoagulation 58 73 58 73 I-treatment
( 74 75 74 75 O
subjects 75 83 75 83 O
intolerant 84 94 84 94 O
to 95 97 95 97 O
aspirin 98 105 98 105 O
may 106 109 106 109 O
use 110 113 110 113 O
warfarin 114 122 114 122 B-treatment
or 123 125 123 125 O
low 126 129 126 129 B-treatment
molecular 130 139 130 139 I-treatment
weight 140 146 140 146 I-treatment
heparin 147 154 147 154 I-treatment
) 154 155 154 155 O
if 156 158 156 158 O
clinically 159 169 159 169 O
indicated 170 179 170 179 O

Absolute 0 8 180 188 B-clinical_variable
neutrophil 9 19 189 199 I-clinical_variable
count 20 25 200 205 I-clinical_variable
> 26 27 206 207 O
= 27 28 207 208 O
1500 29 33 209 213 B-lower_bound
/ 33 34 213 214 I-lower_bound
uL 34 36 214 216 I-lower_bound

All 0 3 217 220 O
study 4 9 221 226 O
participants 10 22 227 239 O
must 23 27 240 244 O
be 28 30 245 247 O
willing 31 38 248 255 O
to 39 41 256 258 O
be 42 44 259 261 O
registered 45 55 262 272 O
into 56 60 273 277 O
the 61 64 278 281 O
mandatory 65 74 282 291 O
Revlimid 75 83 292 300 O
REMS 84 88 301 305 O
program 89 96 306 313 O
after 97 102 314 319 O
completion 103 113 320 330 O
of 114 116 331 333 O
induction 117 126 334 343 O
chemoimmunotherapy 127 145 344 362 B-treatment
and 146 149 363 366 O
prior 150 155 367 372 O
to 156 158 373 375 O
maintenance 159 170 376 387 O
therapy 171 178 388 395 O

Any 0 3 396 399 O
serious 4 11 400 407 O
medical 12 19 408 415 O
condition 20 29 416 425 O
, 29 30 425 426 O
laboratory 31 41 427 437 O
abnormality 42 53 438 449 O
, 53 54 449 450 O
or 55 57 451 453 O
psychiatric 58 69 454 465 B-chronic_disease
illness 70 77 466 473 I-chronic_disease
that 78 82 474 478 O
would 83 88 479 484 O
prevent 89 96 485 492 O
the 97 100 493 496 O
subject 101 108 497 504 O
from 109 113 505 509 O
signing 114 121 510 517 O
the 122 125 518 521 O
informed 126 134 522 530 O
consent 135 142 531 538 O
document 143 151 539 547 O
or 152 154 548 550 O
complying 155 164 551 560 O
with 165 169 561 565 O
the 170 173 566 569 O
protocol 174 182 570 578 O
treatment 183 192 579 588 B-treatment

Chronic 0 7 589 596 O
hepatitis 8 17 597 606 B-chronic_disease
B 18 19 607 608 I-chronic_disease
or 20 22 609 611 O
hepatitis 23 32 612 621 B-chronic_disease
C 33 34 622 623 I-chronic_disease
infection 35 44 624 633 O

Concurrent 0 10 634 644 O
use 11 14 645 648 O
of 15 17 649 651 O
other 18 23 652 657 O
anti 24 28 658 662 B-treatment
- 28 29 662 663 I-treatment
cancer 29 35 663 669 I-treatment
agents 36 42 670 676 I-treatment
or 43 45 677 679 O
treatments 46 56 680 690 B-treatment

Disease 0 7 691 698 O
- 7 8 698 699 O
free 8 12 699 703 O
of 13 15 704 706 O
prior 16 21 707 712 O
malignancies 22 34 713 725 B-cancer
for 35 38 726 729 O
> 39 40 730 731 O
= 40 41 731 732 O
2 42 43 733 734 B-lower_bound
years 44 49 735 740 I-lower_bound

Eastern 0 7 741 748 B-clinical_variable
Cooperative 8 19 749 760 I-clinical_variable
Oncology 20 28 761 769 I-clinical_variable
Group 29 34 770 775 I-clinical_variable
( 35 36 776 777 I-clinical_variable
ECOG 36 40 777 781 I-clinical_variable
) 40 41 781 782 I-clinical_variable
performance 42 53 783 794 I-clinical_variable
status 54 60 795 801 I-clinical_variable
of 61 63 802 804 O
= 64 65 805 806 O
< 65 66 806 807 O
2 67 68 808 809 B-upper_bound
at 69 71 810 812 O
study 72 77 813 818 O
entry 78 83 819 824 O

FCBP 0 4 825 829 B-clinical_variable
must 5 9 830 834 O
also 10 14 835 839 O
agree 15 20 840 845 O
to 21 23 846 848 O
ongoing 24 31 849 856 O
pregnancy 32 41 857 866 B-pregnancy
testing 42 49 867 874 O
; 49 50 874 875 O
men 51 54 876 879 B-gender
must 55 59 880 884 O
agree 60 65 885 890 B-contraception_consent
to 66 68 891 893 I-contraception_consent
use 69 72 894 897 I-contraception_consent
a 73 74 898 899 I-contraception_consent
latex 75 80 900 905 I-contraception_consent
condom 81 87 906 912 I-contraception_consent
during 88 94 913 919 O
sexual 95 101 920 926 O
contact 102 109 927 934 O
with 110 114 935 939 O
a 115 116 940 941 O
FCBP 117 121 942 946 O
even 122 126 947 951 O
if 127 129 952 954 O
they 130 134 955 959 O
have 135 139 960 964 O
had 140 143 965 968 O
a 144 145 969 970 O
successful 146 156 971 981 O
vasectomy 157 166 982 991 B-treatment

Females 0 7 992 999 B-gender
of 8 10 1000 1002 O
childbearing 11 23 1003 1015 O
potential 24 33 1016 1025 O
( 34 35 1026 1027 O
FCBP 35 39 1027 1031 O
) 39 40 1031 1032 O
must 41 45 1033 1037 O
have 46 50 1038 1042 O
a 51 52 1043 1044 O
negative 53 61 1045 1053 O
serum 62 67 1054 1059 O
or 68 70 1060 1062 O
urine 71 76 1063 1068 O
pregnancy 77 86 1069 1078 B-pregnancy
test 87 91 1079 1083 O
with 92 96 1084 1088 O
a 97 98 1089 1090 O
sensitivity 99 110 1091 1102 O
of 111 113 1103 1105 O
at 114 116 1106 1108 O
least 117 122 1109 1114 O
50 123 125 1115 1117 B-lower_bound
mIU 126 129 1118 1121 I-lower_bound
/ 129 130 1121 1122 I-lower_bound
mL 130 132 1122 1124 I-lower_bound
within 133 139 1125 1131 O
10 140 142 1132 1134 B-lower_bound
- 143 144 1135 1136 O
14 145 147 1137 1139 B-upper_bound
days 148 152 1140 1144 I-upper_bound

Females 0 7 1145 1152 B-gender
of 8 10 1153 1155 O
reproductive 11 23 1156 1168 O
potential 24 33 1169 1178 O
must 34 38 1179 1183 O
adhere 39 45 1184 1190 O
to 46 48 1191 1193 O
the 49 52 1194 1197 O
scheduled 53 62 1198 1207 O
pregnancy 63 72 1208 1217 B-pregnancy
testing 73 80 1218 1225 O
as 81 83 1226 1228 O
required 84 92 1229 1237 O
in 93 95 1238 1240 O
the 96 99 1241 1244 O
Revlimid 100 108 1245 1253 O
REMS 109 113 1254 1258 O
program 114 121 1259 1266 O

Histologically 0 14 1267 1281 O
confirmed 15 24 1282 1291 O
chronic 25 32 1292 1299 B-cancer
lymphocytic 33 44 1300 1311 I-cancer
leukemia 45 53 1312 1320 I-cancer
( 54 55 1321 1322 I-cancer
CLL)/small 55 65 1322 1332 I-cancer
lymphocytic 66 77 1333 1344 I-cancer
lymphoma 78 86 1345 1353 I-cancer
( 87 88 1354 1355 I-cancer
SLL 88 91 1355 1358 I-cancer
) 91 92 1358 1359 I-cancer

Known 0 5 1360 1365 O
hypersensitivity 6 22 1366 1382 O
to 23 25 1383 1385 O
thalidomide 26 37 1386 1397 B-allergy_name

Known 0 5 1398 1403 O
to 6 8 1404 1406 O
be 9 11 1407 1409 O
positive 12 20 1410 1418 O
for 21 24 1419 1422 O
human 25 30 1423 1428 B-chronic_disease
immunodeficiency 31 47 1429 1445 I-chronic_disease
virus 48 53 1446 1451 I-chronic_disease
( 54 55 1452 1453 I-chronic_disease
HIV 55 58 1453 1456 I-chronic_disease
) 58 59 1456 1457 I-chronic_disease
or 60 62 1458 1460 O
infectious 63 73 1461 1471 B-chronic_disease
hepatitis 74 83 1472 1481 I-chronic_disease
( 84 85 1482 1483 I-chronic_disease
type 85 89 1483 1487 I-chronic_disease
B 90 91 1488 1489 I-chronic_disease
or 92 94 1490 1492 I-chronic_disease
C 95 96 1493 1494 I-chronic_disease
) 96 97 1494 1495 I-chronic_disease

Life 0 4 1496 1500 B-clinical_variable
expectancy 5 15 1501 1511 I-clinical_variable
of 16 18 1512 1514 O
at 19 21 1515 1517 O
least 22 27 1518 1523 O
3 28 29 1524 1525 B-lower_bound
months 30 36 1526 1532 I-lower_bound

More 0 4 1533 1537 O
than 5 9 1538 1542 O
one 10 13 1543 1546 B-lower_bound
grade 14 19 1547 1552 O
2 20 21 1553 1554 O
or 22 24 1555 1557 O
higher 25 31 1558 1564 O
transaminase 32 44 1565 1577 O
elevation 45 54 1578 1587 O

New 0 3 1588 1591 B-clinical_variable
York 4 8 1592 1596 I-clinical_variable
Heart 9 14 1597 1602 I-clinical_variable
Association 15 26 1603 1614 I-clinical_variable
class 27 32 1615 1620 I-clinical_variable
3 33 34 1621 1622 B-lower_bound
- 34 35 1622 1623 O
4 35 36 1623 1624 B-upper_bound
heart 37 42 1625 1630 B-chronic_disease
failure 43 50 1631 1638 I-chronic_disease

No 0 2 1639 1641 O
prior 3 8 1642 1647 B-treatment
cytotoxic 9 18 1648 1657 I-treatment
chemotherapy 19 31 1658 1670 I-treatment
for 32 35 1671 1674 O
their 36 41 1675 1680 O
disease 42 49 1681 1688 O

Platelet 0 8 1689 1697 B-clinical_variable
count 9 14 1698 1703 I-clinical_variable
> 15 16 1704 1705 O
= 16 17 1705 1706 O
100,000 18 25 1707 1714 B-lower_bound
/ 25 26 1714 1715 I-lower_bound
uL 26 28 1715 1717 I-lower_bound

Pregnant 0 8 1718 1726 B-pregnancy
or 9 11 1727 1729 O
breast 12 18 1730 1736 O
- 18 19 1736 1737 O
feeding 19 26 1737 1744 O
females 27 34 1745 1752 B-gender

Prior 0 5 1753 1758 O
malignancy 6 16 1759 1769 B-cancer
, 16 17 1769 1770 O
except 18 24 1771 1777 O
for 25 28 1778 1781 O
adequately 29 39 1782 1792 O
treated 40 47 1793 1800 O
basal 48 53 1801 1806 B-cancer
cell 54 58 1807 1811 I-cancer
or 59 61 1812 1814 O
squamous 62 70 1815 1823 B-cancer
cell 71 75 1824 1828 I-cancer
skin 76 80 1829 1833 I-cancer
cancer 81 87 1834 1840 I-cancer
, 87 88 1840 1841 O
in 89 91 1842 1844 B-cancer
situ 92 96 1845 1849 I-cancer
cervical 97 105 1850 1858 I-cancer
or 106 108 1859 1861 O
breast 109 115 1862 1868 B-cancer
cancer 116 122 1869 1875 I-cancer
, 122 123 1875 1876 O
or 124 126 1877 1879 O
other 127 132 1880 1885 O
cancer 133 139 1886 1892 O
from 140 144 1893 1897 O
which 145 150 1898 1903 O
the 151 154 1904 1907 O
subject 155 162 1908 1915 O
has 163 166 1916 1919 O
been 167 171 1920 1924 O
disease 172 179 1925 1932 O
free 180 184 1933 1937 O
for 185 188 1938 1941 O
at 189 191 1942 1944 O
least 192 197 1945 1950 O
2 198 199 1951 1952 B-lower_bound
years 200 205 1953 1958 I-lower_bound

Prior 0 5 1959 1964 O
therapy 6 13 1965 1972 B-treatment
with 14 18 1973 1977 O
rituximab 19 28 1978 1987 B-treatment
is 29 31 1988 1990 O
permitted 32 41 1991 2000 O
, 41 42 2000 2001 O
even 43 47 2002 2006 O
in 48 50 2007 2009 O
the 51 54 2010 2013 O
setting 55 62 2014 2021 O
of 63 65 2022 2024 O
rituximab 66 75 2025 2034 B-chronic_disease
- 75 76 2034 2035 I-chronic_disease
refractory 76 86 2035 2045 I-chronic_disease
disease 87 94 2046 2053 I-chronic_disease

Serum 0 5 2054 2059 B-clinical_variable
alkaline 6 14 2060 2068 I-clinical_variable
phosphatase 15 26 2069 2080 I-clinical_variable
= 27 28 2081 2082 O
< 28 29 2082 2083 O
5 30 31 2084 2085 B-upper_bound
x 32 33 2086 2087 I-upper_bound
ULN 34 37 2088 2091 I-upper_bound

Serum 0 5 2092 2097 B-clinical_variable
transaminases 6 19 2098 2111 I-clinical_variable
aspartate 20 29 2112 2121 I-clinical_variable
aminotransferase 30 46 2122 2138 I-clinical_variable
( 47 48 2139 2140 I-clinical_variable
AST 48 51 2140 2143 I-clinical_variable
) 51 52 2143 2144 I-clinical_variable
( 53 54 2145 2146 B-clinical_variable
serum 54 59 2146 2151 I-clinical_variable
glutamic 60 68 2152 2160 I-clinical_variable
oxaloacetic 69 80 2161 2172 I-clinical_variable
transaminase 81 93 2173 2185 I-clinical_variable
[ 94 95 2186 2187 I-clinical_variable
SGOT 95 99 2187 2191 I-clinical_variable
] 99 100 2191 2192 I-clinical_variable
) 100 101 2192 2193 I-clinical_variable
and 102 105 2194 2197 O
alanine 106 113 2198 2205 B-clinical_variable
aminotransferase 114 130 2206 2222 I-clinical_variable
( 131 132 2223 2224 I-clinical_variable
ALT 132 135 2224 2227 I-clinical_variable
) 135 136 2227 2228 I-clinical_variable
( 137 138 2229 2230 B-clinical_variable
serum 138 143 2230 2235 I-clinical_variable
glutamate 144 153 2236 2245 I-clinical_variable
pyruvate 154 162 2246 2254 I-clinical_variable
transaminase 163 175 2255 2267 I-clinical_variable
[ 176 177 2268 2269 I-clinical_variable
SGPT 177 181 2269 2273 I-clinical_variable
] 181 182 2273 2274 I-clinical_variable
) 182 183 2274 2275 I-clinical_variable
= 184 185 2276 2277 O
< 185 186 2277 2278 O
5 187 188 2279 2280 B-upper_bound
x 189 190 2281 2282 I-upper_bound
ULN 191 194 2283 2286 I-upper_bound

Severe 0 6 2287 2293 O
or 7 9 2294 2296 O
life 10 14 2297 2301 O
- 14 15 2301 2302 O
threatening 15 26 2302 2313 O
anaphylaxis 27 38 2314 2325 B-chronic_disease
or 39 41 2326 2328 O
hypersensitivity 42 58 2329 2345 O
reaction 59 67 2346 2354 O
when 68 72 2355 2359 O
previously 73 83 2360 2370 O
exposed 84 91 2371 2378 O
to 92 94 2379 2381 O
rituximab 95 104 2382 2391 B-allergy_name
or 105 107 2392 2394 O
other 108 113 2395 2400 O
monoclonal 114 124 2401 2411 B-allergy_name
antibody 125 133 2412 2420 I-allergy_name
therapy 134 141 2421 2428 I-allergy_name

Subjects 0 8 2429 2437 O
are 9 12 2438 2441 O
not 13 16 2442 2445 O
eligible 17 25 2446 2454 O
if 26 28 2455 2457 O
there 29 34 2458 2463 O
is 35 37 2464 2466 O
a 38 39 2467 2468 O
prior 40 45 2469 2474 O
history 46 53 2475 2482 O
or 54 56 2483 2485 O
current 57 64 2486 2493 O
evidence 65 73 2494 2502 O
of 74 76 2503 2505 O
central 77 84 2506 2513 B-chronic_disease
nervous 85 92 2514 2521 I-chronic_disease
system 93 99 2522 2528 I-chronic_disease
or 100 102 2529 2531 O
leptomeningeal 103 117 2532 2546 B-chronic_disease
involvement 118 129 2547 2558 O

Subjects 0 8 2559 2567 O
must 9 13 2568 2572 O
have 14 18 2573 2577 O
adequate 19 27 2578 2586 O
renal 28 33 2587 2592 O
function 34 42 2593 2601 O
with 43 47 2602 2606 O
a 48 49 2607 2608 O
creatinine 50 60 2609 2619 B-clinical_variable
clearance 61 70 2620 2629 I-clinical_variable
of 71 73 2630 2632 O
> 74 75 2633 2634 O
= 75 76 2634 2635 O
40 77 79 2636 2638 B-lower_bound
mL 80 82 2639 2641 I-lower_bound
/ 82 83 2641 2642 I-lower_bound
min 83 86 2642 2645 I-lower_bound
as 87 89 2646 2648 O
determined 90 100 2649 2659 O
by 101 103 2660 2662 O
the 104 107 2663 2666 O
Cockcroft 108 117 2667 2676 B-clinical_variable
- 117 118 2676 2677 I-clinical_variable
Gault 118 123 2677 2682 I-clinical_variable
calculation 124 135 2683 2694 I-clinical_variable

Subjects 0 8 2695 2703 O
must 9 13 2704 2708 O
not 14 17 2709 2712 O
have 18 22 2713 2717 O
a 23 24 2718 2719 O
known 25 30 2720 2725 O
history 31 38 2726 2733 O
of 39 41 2734 2736 O
hypersensitivity 42 58 2737 2753 O
to 59 61 2754 2756 O
mannitol 62 70 2757 2765 B-allergy_name

Subjects 0 8 2766 2774 O
with 9 13 2775 2779 O
neutrophils 14 25 2780 2791 B-clinical_variable
< 26 27 2792 2793 O
1500 28 32 2794 2798 B-upper_bound
/ 32 33 2798 2799 I-upper_bound
uL 33 35 2799 2801 I-upper_bound
or 36 38 2802 2804 O
platelets 39 48 2805 2814 B-clinical_variable
< 49 50 2815 2816 O
100,000 51 58 2817 2824 B-upper_bound
/ 58 59 2824 2825 I-upper_bound
uL 59 61 2825 2827 I-upper_bound
with 62 66 2828 2832 O
splenomegaly 67 79 2833 2845 B-chronic_disease
or 80 82 2846 2848 O
extensive 83 92 2849 2858 O
bone 93 97 2859 2863 O
marrow 98 104 2864 2870 O
involvement 105 116 2871 2882 O
as 117 119 2883 2885 O
the 120 123 2886 2889 O
etiology 124 132 2890 2898 O
for 133 136 2899 2902 O
their 137 142 2903 2908 O
cytopenias 143 153 2909 2919 B-chronic_disease
are 154 157 2920 2923 O
eligible 158 166 2924 2932 O

Total 0 5 2933 2938 B-clinical_variable
bilirubin 6 15 2939 2948 I-clinical_variable
= 16 17 2949 2950 O
< 17 18 2950 2951 O
2 19 20 2952 2953 B-upper_bound
x 21 22 2954 2955 I-upper_bound
upper 23 28 2956 2961 I-upper_bound
limit 29 34 2962 2967 I-upper_bound
laboratory 35 45 2968 2978 I-upper_bound
normal 46 52 2979 2985 I-upper_bound
( 53 54 2986 2987 I-upper_bound
ULN 54 57 2987 2990 I-upper_bound
) 57 58 2990 2991 I-upper_bound
; 58 59 2991 2992 O
subjects 60 68 2993 3001 O
with 69 73 3002 3006 O
non 74 77 3007 3010 O
- 77 78 3010 3011 O
clinically 78 88 3011 3021 O
significant 89 100 3022 3033 O
elevations 101 111 3034 3044 O
of 112 114 3045 3047 O
bilirubin 115 124 3048 3057 O
due 125 128 3058 3061 O
to 129 131 3062 3064 O
Gilbert 132 139 3065 3072 B-chronic_disease
's 139 141 3072 3074 I-chronic_disease
disease 142 149 3075 3082 I-chronic_disease
are 150 153 3083 3086 O
not 154 157 3087 3090 O
required 158 166 3091 3099 O
to 167 169 3100 3102 O
meet 170 174 3103 3107 O
these 175 180 3108 3113 O
criteria 181 189 3114 3122 O

at 0 2 3123 3125 O
least 3 8 3126 3131 O
28 9 11 3132 3134 B-lower_bound
days 12 16 3135 3139 I-lower_bound
before 17 23 3140 3146 O
she 24 27 3147 3150 O
starts 28 34 3151 3157 O
taking 35 41 3158 3164 O
lenalidomide 42 54 3165 3177 B-treatment

basal 0 5 3178 3183 B-cancer
or 6 8 3184 3186 O
squamous 9 17 3187 3195 B-cancer
cell 18 22 3196 3200 I-cancer
skin 23 27 3201 3205 I-cancer
carcinoma 28 37 3206 3215 I-cancer

carcinoma 0 9 3216 3225 B-cancer
in 10 12 3226 3228 I-cancer
situ 13 17 3229 3233 I-cancer
of 18 20 3234 3236 I-cancer
the 21 24 3237 3240 I-cancer
breast 25 31 3241 3247 I-cancer
or 32 34 3248 3250 O
cervix 35 41 3251 3257 B-cancer

lactating 0 9 3258 3267 O
females 10 17 3268 3275 B-gender
must 18 22 3276 3280 O
agree 23 28 3281 3286 O
not 29 32 3287 3290 O
to 33 35 3291 3293 O
breast 36 42 3294 3300 O
- 42 43 3300 3301 O
feed 43 47 3301 3305 O
while 48 53 3306 3311 O
taking 54 60 3312 3318 O
lenalidomide 61 73 3319 3331 B-treatment

localized 0 9 3332 3341 B-cancer
prostate 10 18 3342 3350 I-cancer
cancer 19 25 3351 3357 I-cancer
( 26 27 3358 3359 O
treated 27 34 3359 3366 O
definitively 35 47 3367 3379 O
with 48 52 3380 3384 O
hormone 53 60 3385 3392 B-treatment
therapy 61 68 3393 3400 I-treatment
, 68 69 3400 3401 O
radiotherapy 70 82 3402 3414 B-treatment
, 82 83 3414 3415 O
or 84 86 3416 3418 O
surgery 87 94 3419 3426 B-treatment
) 94 95 3426 3427 O

prior 0 5 3428 3433 B-treatment
therapy 6 13 3434 3441 I-treatment
with 14 18 3442 3446 I-treatment
single 19 25 3447 3453 I-treatment
- 25 26 3453 3454 I-treatment
agent 26 31 3454 3459 I-treatment
rituximab 32 41 3460 3469 I-treatment
is 42 44 3470 3472 O
permitted 45 54 3473 3482 O

within 0 6 3483 3489 O
24 7 9 3490 3492 B-upper_bound
hours 10 15 3493 3498 I-upper_bound
prior 16 21 3499 3504 I-upper_bound
to 22 24 3505 3507 O
prescribing 25 36 3508 3519 O
lenalidomide 37 49 3520 3532 B-treatment
for 50 53 3533 3536 O
cycle 54 59 3537 3542 O
1 60 61 3543 3544 O
( 62 63 3545 3546 O
prescriptions 63 76 3546 3559 O
must 77 81 3560 3564 O
be 82 84 3565 3567 O
filled 85 91 3568 3574 O
within 92 98 3575 3581 O
7 99 100 3582 3583 B-upper_bound
days 101 105 3584 3588 I-upper_bound
as 106 108 3589 3591 O
required 109 117 3592 3600 O
by 118 120 3601 3603 O
the 121 124 3604 3607 O
Revlimid 125 133 3608 3616 B-treatment
REMS 134 138 3617 3621 I-treatment
Â® 138 139 3621 3622 I-treatment
program 140 147 3623 3630 I-treatment
) 147 148 3630 3631 O
and 149 152 3632 3635 O
must 153 157 3636 3640 O
either 158 164 3641 3647 O
commit 165 171 3648 3654 B-contraception_consent
to 172 174 3655 3657 I-contraception_consent
continued 175 184 3658 3667 I-contraception_consent
abstinence 185 195 3668 3678 I-contraception_consent
from 196 200 3679 3683 I-contraception_consent
heterosexual 201 213 3684 3696 I-contraception_consent
intercourse 214 225 3697 3708 I-contraception_consent
or 226 228 3709 3711 O
begin 229 234 3712 3717 B-contraception_consent
TWO 235 238 3718 3721 I-contraception_consent
acceptable 239 249 3722 3732 I-contraception_consent
methods 250 257 3733 3740 I-contraception_consent
of 258 260 3741 3743 I-contraception_consent
birth 261 266 3744 3749 I-contraception_consent
control 267 274 3750 3757 I-contraception_consent
, 274 275 3757 3758 O
one 276 279 3759 3762 O
highly 280 286 3763 3769 O
effective 287 296 3770 3779 O
method 297 303 3780 3786 O
and 304 307 3787 3790 O
one 308 311 3791 3794 O
additional 312 322 3795 3805 O
effective 323 332 3806 3815 O
method 333 339 3816 3822 O
AT 340 342 3823 3825 O
THE 343 346 3826 3829 O
SAME 347 351 3830 3834 O
TIME 352 356 3835 3839 O

